Skip to content
10-K

Annual Report

STANDARD BIOTOOLS INC. LAB

0001193125-26-108326

← back to feed
Filed
Mar 16, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 12, 2026 390.07M sh
Shares Diluted FY 2025 · Dec 31, 2025 381.62M sh
Shares Diluted FY 2025 · Dec 31, 2024 353.25M sh
Shares Diluted FY 2025 · Dec 31, 2023 79.16M sh
Stock Repurchased FY 2025 · Dec 31, 2025 $0
Stock Repurchased FY 2025 · Dec 31, 2024 $40.49M
Stock Repurchased FY 2025 · Dec 31, 2023 $5.41M
Capex FY 2025 · Dec 31, 2025 $8.3M
Capex FY 2025 · Dec 31, 2024 $8.36M
Capex FY 2025 · Dec 31, 2023 $2.83M
Operating Cash Flow FY 2025 · Dec 31, 2025 −$74.34M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$143.45M
Operating Cash Flow FY 2025 · Dec 31, 2023 −$43.29M
Cash And Equivalents FY 2025 · Dec 31, 2025 $120.86M
Cash And Equivalents FY 2025 · Dec 31, 2024 $166.73M
Stockholders Equity FY 2025 · Dec 31, 2025 $424.29M
Stockholders Equity FY 2025 · Dec 31, 2024 $471.72M
Stockholders Equity FY 2025 · Dec 31, 2023 −$148.05M
Stockholders Equity FY 2025 · Dec 31, 2022 −$81.47M
Current Liabilities FY 2025 · Dec 31, 2025 $108.31M
Current Liabilities restated FY 2025 · Dec 31, 2024 $65.9M
Total Liabilities FY 2025 · Dec 31, 2025 $143.46M
Total Liabilities restated FY 2025 · Dec 31, 2024 $140.62M
Current Assets FY 2025 · Dec 31, 2025 $454.26M
Current Assets restated FY 2025 · Dec 31, 2024 $375.88M
Total Assets FY 2025 · Dec 31, 2025 $567.75M
Total Assets restated FY 2025 · Dec 31, 2024 $612.35M
Eps Diluted FY 2025 · Dec 31, 2025 −$0.20
Eps Diluted FY 2025 · Dec 31, 2024 −$0.52
Eps Diluted FY 2025 · Dec 31, 2023 −$0.94
Eps Basic FY 2025 · Dec 31, 2025 −$0.20
Eps Basic FY 2025 · Dec 31, 2024 −$0.52
Eps Basic FY 2025 · Dec 31, 2023 −$0.94
Sga Expense FY 2025 · Dec 31, 2025 $109.86M
Sga Expense restated FY 2025 · Dec 31, 2024 $103.06M
Sga Expense FY 2025 · Dec 31, 2023 $87.54M
Rd Expense FY 2025 · Dec 31, 2025 $25.99M
Rd Expense restated FY 2025 · Dec 31, 2024 $28.83M
Rd Expense FY 2025 · Dec 31, 2023 $25.95M
Net Income FY 2025 · Dec 31, 2025 −$74.9M
Net Income FY 2025 · Dec 31, 2024 −$138.89M
Net Income FY 2025 · Dec 31, 2023 −$74.66M
Operating Income FY 2025 · Dec 31, 2025 −$110.25M
Operating Income restated FY 2025 · Dec 31, 2024 −$127.49M
Operating Income FY 2025 · Dec 31, 2023 −$76.6M
Gross Profit FY 2025 · Dec 31, 2025 $42.54M
Gross Profit restated FY 2025 · Dec 31, 2024 $44.88M
Gross Profit FY 2025 · Dec 31, 2023 $50.45M
Revenue FY 2025 · Dec 31, 2025 $85.33M
Revenue restated FY 2025 · Dec 31, 2024 $91.01M
Revenue FY 2025 · Dec 31, 2023 $106.34M